Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope StructureImmunity (Cambridge, Mass.), 2018-05, Vol.48 (5), p.855-871 [Peer Reviewed Journal]2018 ;Published by Elsevier Inc. ;Copyright Elsevier Limited May 15, 2018 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2018.04.029 ;PMID: 29768174Full text available |
|
2 |
Material Type: Article
|
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell OntogeniesImmunity (Cambridge, Mass.), 2012-09, Vol.37 (3), p.412-425 [Peer Reviewed Journal]2012 Elsevier Inc. ;Copyright © 2012 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Sep 21, 2012 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2012.08.012 ;PMID: 22999947Full text available |
|
3 |
Material Type: Article
|
A strategic approach to COVID-19 vaccine R&DScience, 2020-05, Vol.368 (6494) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/science.abc5312Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
HIV-1 neutralizing antibodies: understanding nature's pathwaysImmunological reviews, 2013-07, Vol.254 (1), p.225-244 [Peer Reviewed Journal]Published 2013. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 0105-2896 ;EISSN: 1600-065X ;DOI: 10.1111/imr.12075 ;PMID: 23772623Full text available |
|
5 |
Material Type: Article
|
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginningNature reviews. Immunology, 2013-09, Vol.13 (9), p.693-701 [Peer Reviewed Journal]COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2013 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/nri3516 ;PMID: 23969737Full text available |
|
6 |
Material Type: Article
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923Full text available |
|
7 |
Material Type: Article
|
An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicine, 2020-11, Vol.383 (20), p.1920-1931 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022483 ;PMID: 32663912Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteCell, 2015-08, Vol.162 (5), p.1090-1100 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright © 2015 Elsevier Inc. All rights reserved. 2015 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2015.07.043 ;PMID: 26279189Full text available |
|
10 |
Material Type: Article
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesNature (London), 2016-05, Vol.533 (7601), p.105-109 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group May 5, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature17677 ;PMID: 27120156 ;CODEN: NATUASFull text available |
|
11 |
Material Type: Article
|
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing AntibodiesCell, 2014-07, Vol.158 (3), p.481-491 [Peer Reviewed Journal]2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;2014 Elsevier Inc. All rights reserved. 2014 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2014.06.022 ;PMID: 25065977Full text available |
|
12 |
Material Type: Article
|
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeCell reports (Cambridge), 2016-08, Vol.16 (6), p.1485-1491 [Peer Reviewed Journal]2016 ;Published by Elsevier Inc. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2016.07.049 ;PMID: 27481466Full text available |
|
13 |
Material Type: Article
|
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus ParticlesCell Host & Microbe, 2020-12, Vol.28 (6), p.880-891.e8 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.001 ;PMID: 33242391Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
A Monoclonal Antibody for Malaria PreventionThe New England journal of medicine, 2021-08, Vol.385 (9), p.803-814 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034031 ;PMID: 34379916Full text available |
|
15 |
Material Type: Article
|
Broad and potent neutralization of HIV―1 by a gp41―specific human antibodyNature (London), 2012-11, Vol.491 (7424), p.406-412 [Peer Reviewed Journal]2014 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Nov 15, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature11544 ;PMID: 23151583 ;CODEN: NATUASFull text available |
|
16 |
Material Type: Article
|
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization BreadthImmunity (Cambridge, Mass.), 2016-11, Vol.45 (5), p.1108-1121 [Peer Reviewed Journal]2016 ;Published by Elsevier Inc. ;Copyright Elsevier Limited Nov 15, 2016 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2016.10.027 ;PMID: 27851912Full text available |
|
17 |
Material Type: Article
|
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionNature (London), 2014-10, Vol.514 (7524), p.642-645 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 30, 2014 ;2014 Macmillan Publishers Limited. All rights reserved 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature13612 ;PMID: 25119033 ;CODEN: NATUASFull text available |
|
18 |
Material Type: Article
|
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsPLoS pathogens, 2018-03, Vol.14 (3), p.e1006860-e1006860 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006860 ;PMID: 29505593Full text available |
|
19 |
Material Type: Article
|
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesThe Journal of experimental medicine, 2014-09, Vol.211 (10), p.2061-2074 [Peer Reviewed Journal]2014 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20132494 ;PMID: 25155019Full text available |
|
20 |
Material Type: Article
|
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyCell, 2016-04, Vol.165 (2), p.449-463 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.02.022 ;PMID: 26949186Full text available |